IL30747A - Acylated n-(alkylaminoalkyl)-aminopyridines - Google Patents
Acylated n-(alkylaminoalkyl)-aminopyridinesInfo
- Publication number
- IL30747A IL30747A IL30747A IL3074768A IL30747A IL 30747 A IL30747 A IL 30747A IL 30747 A IL30747 A IL 30747A IL 3074768 A IL3074768 A IL 3074768A IL 30747 A IL30747 A IL 30747A
- Authority
- IL
- Israel
- Prior art keywords
- prepared
- reacting
- method described
- propionyl
- starting material
- Prior art date
Links
- 239000000203 mixture Substances 0.000 claims description 13
- 150000001875 compounds Chemical class 0.000 claims description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 229910052799 carbon Inorganic materials 0.000 claims description 6
- 125000000623 heterocyclic group Chemical group 0.000 claims description 6
- 229920006395 saturated elastomer Polymers 0.000 claims description 6
- 230000000202 analgesic effect Effects 0.000 claims description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 150000003222 pyridines Chemical class 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 3
- 125000003342 alkenyl group Chemical group 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 238000000034 method Methods 0.000 description 37
- 239000007858 starting material Substances 0.000 description 31
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 29
- 150000004985 diamines Chemical class 0.000 description 21
- 238000010438 heat treatment Methods 0.000 description 20
- BULLHNJGPPOUOX-UHFFFAOYSA-N chloroacetone Chemical compound CC(=O)CCl BULLHNJGPPOUOX-UHFFFAOYSA-N 0.000 description 17
- 150000003927 aminopyridines Chemical class 0.000 description 14
- JFBZPFYRPYOZCQ-UHFFFAOYSA-N [Li].[Al] Chemical compound [Li].[Al] JFBZPFYRPYOZCQ-UHFFFAOYSA-N 0.000 description 12
- -1 alkylene radical Chemical class 0.000 description 11
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 10
- 239000002253 acid Substances 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- GKIRPKYJQBWNGO-OCEACIFDSA-N clomifene Chemical compound C1=CC(OCCN(CC)CC)=CC=C1C(\C=1C=CC=CC=1)=C(\Cl)C1=CC=CC=C1 GKIRPKYJQBWNGO-OCEACIFDSA-N 0.000 description 6
- 229940075930 picrate Drugs 0.000 description 5
- OXNIZHLAWKMVMX-UHFFFAOYSA-M picrate anion Chemical compound [O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-M 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- 238000004508 fractional distillation Methods 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- XYOVOXDWRFGKEX-UHFFFAOYSA-N azepine Chemical compound N1C=CC=CC=C1 XYOVOXDWRFGKEX-UHFFFAOYSA-N 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- RZWZRACFZGVKFM-UHFFFAOYSA-N propanoyl chloride Chemical compound CCC(Cl)=O RZWZRACFZGVKFM-UHFFFAOYSA-N 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 2
- VSWICNJIUPRZIK-UHFFFAOYSA-N 2-piperideine Chemical compound C1CNC=CC1 VSWICNJIUPRZIK-UHFFFAOYSA-N 0.000 description 2
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- ZSIQJIWKELUFRJ-UHFFFAOYSA-N azepane Chemical compound C1CCCNCC1 ZSIQJIWKELUFRJ-UHFFFAOYSA-N 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 238000006798 ring closing metathesis reaction Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- DRTQHJPVMGBUCF-UCVXFZOQSA-N 1-[(2s,3s,4s,5s)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione Chemical compound O[C@H]1[C@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UCVXFZOQSA-N 0.000 description 1
- PAMIQIKDUOTOBW-UHFFFAOYSA-N 1-methylpiperidine Chemical compound CN1CCCCC1 PAMIQIKDUOTOBW-UHFFFAOYSA-N 0.000 description 1
- XOFNHZHCGBPVGJ-UHFFFAOYSA-N 5-ethyl-2-methylpiperidine Chemical compound CCC1CCC(C)NC1 XOFNHZHCGBPVGJ-UHFFFAOYSA-N 0.000 description 1
- INMFOCKBAIPRDA-UHFFFAOYSA-N C1([N+](=O)[O-])=CC([N+](=O)[O-])=CC([N+](=O)[O-])=C1O.N1C=CC=CC=C1 Chemical compound C1([N+](=O)[O-])=CC([N+](=O)[O-])=CC([N+](=O)[O-])=C1O.N1C=CC=CC=C1 INMFOCKBAIPRDA-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 238000006923 Schmidt rearrangement reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000003855 acyl compounds Chemical class 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- JJCFRYNCJDLXIK-UHFFFAOYSA-N cyproheptadine Chemical compound C1CN(C)CCC1=C1C2=CC=CC=C2C=CC2=CC=CC=C21 JJCFRYNCJDLXIK-UHFFFAOYSA-N 0.000 description 1
- HPYNZHMRTTWQTB-UHFFFAOYSA-N dimethylpyridine Natural products CC1=CC=CN=C1C HPYNZHMRTTWQTB-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- PFWWZGINJSDVGU-UHFFFAOYSA-N piperidine Chemical compound C1CCNCC1.C1CCNCC1 PFWWZGINJSDVGU-UHFFFAOYSA-N 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 239000011369 resultant mixture Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Closures For Containers (AREA)
Description
BAYER Invention concerns new acyleted The German patent specification describes a process the production of pyridine derivatives having analgesic by acylating of the in which R is a or branched alkylene radical of carbon is a saturated or unsaturated aliphatic hydrocarbon radical of carbon atoms or a lower aralkyl and is hydrogen or a saturated or unsaturated phatic hydrocarbon radical of carbon or together with either or R and the adjacent nitrogen atom may form a or membered heterocyclic The present invention provides new acylated pyridine derivatives having a stronger and better analgesic effect and an advantageous therapeutic as will be shown The invention consists in new acylated of the in which X is a saturated or unsaturated bivalent aliphatic hydrocarbon radical of carbon which is branched once or several times and forms with the nitrogen atom a to membered heterocyclic bearing at least one alkyl with the proviso that the total number of carbon atoms on the heterocyclic ring the alkyl Is from 5 to and is hydrogen or an alkyl or alkenyl group of carbon is reacted an aliphatic acylating agent which contains 1 5 carbon in which formula X has the same meaning as This process is carried out a conventional acylating agents may for saturated or saturated aliphatic carboxylic acid halides or anhydrides or their corresponding mixed used as starting materials which have not been described in the literature can be prepared by known For aminopyridines can be alkylated with corresponding isopropyl halides in the presence of sodium Prom the resultant mixture of the two the desired isomer can be separated by known as by crystallization suitable and the purity can be controlled with the aid of the The isopropyl halides mentioned above are for In known manner by the reaction of propylene oxide with corresponding heterocyclic amines and subsequent halogen of the resultant for with thlonyl the synthesis of the aforesaid can also be carried out by reacting corresponding heterocyclic amines with catalytically reducing the resultant amlnoketones in the presence of and heating the resultant primary with halopyrldlnes in the presence of copper bronze and potassium H CI CO X Suitable heterocyclic amines of the formula X NH in which X has the meaning stated above for the and and and 3 3 j and 2 2 piperidine piperidine The acyl compounds so obtained are oils which be distilled in a vacuum and which form salts with pharmacologically unobjectionable inorganic or organic Suitable acids for hydrochloric sulphuric nitric phosphoric eulphonic acetic succinic glutarlc maleic fumaric tartaric citric mandelic acid and The new compounds are racemates and can therefore be resolved in known manner into their optically active Dosage forms suitable for pharmaceutical application for injectable which can be administered in amounts aminopyridine of 158 mm The starting material is prepared as described in Example 1 by reacting with chloroacetone to form the mm reducing the latter in the presence of and heating the resultant diamine mm with EXAMPLE 3 By the method described in Example 1 there is from g of h pyridine 132 133e mm and g of g of of 162 The starting material is prepared by with chloroacetone to form the mm catalytically reducing the latter in the presence of and heating the resultant diamine mm with EXAMPLE 4 By the method described in Example 1 there is obtained from 33 g of mm and g of propionyl g of of 156 mm The starting material is prepared by reacting jdimeth with chloroacetone to form the aminoketone 92 mm catalytically reducing the latter the presence of and heating the resultant diamine mm with EXAMPLE 5 By the method described in Example 1 there is from g of aminopyrldlne 120 mm and g of propionyl g of of 148 mm The starting material is prepared by reacting with chloroacetone to form the aminoketone mm catalytically reducing the latter in the presence of and heating the resultant diamine 72 mm with EXAMPLE 6 By the method described in Example 1 there is from 29 g of 126 mm and g of propionyl g of of 153 mm The starting material is prepared by reacting with chloroacetone to form the aminoketone mm catalytically reducing the latter in the presence of and heating the resultant diamine 79 mm with EXAMPLE 7 30 g of aminopyridine and 50 ml of acetic acid anhydride are at C for 8 the mixture then concentrated by evaporation in a vacuum and the residue taken up with The base is precipitated from the solution with a hydroxide the product is taken up with ether and dried with potassium After driving off the the mixture is distilled in a vacuum and there are obtained g of aminopyridine of 151 mm EXAMPLE 8 By the method described in Example 7 there from 30 g of and 50 ml of propionic acid g of the aminopyridine of 156 mm Hg described in Example EXAMPLE 9 By the method described in Example 7 there is from 30 g of and 60 g of valerianic acid g of pyridine of 180 mm EXAMPLE 10 By the described in Example 1 there is obtained from 30 g of 149 mm and g of propionyl g of of 164 mm The starting material is prepared by reactin with chloroacetone to form the ketone 93 mm reducing the latter in the presence of and heating the 88 EXAMPLE 11 By the method described 1 there is from 25 g of mm and ICS of 173 mm The starting material is prepared by reacting with chloroacetone to form the aminoketone 101 mm catalytically reducing the latter in the presence of and heating the resultant diamine 94 mm with Ey the method described Example 1 there from 38 g mm and g propionyl g of The starting material is prepared by reacting piperidine with chloroacetone to form catalytically reducing the latter the presence of and heating the resultant diamine 92 with 13 By the method described in Example β are reacted with 9 g propionyl chloride in methylene After removing the solvent in a the crystallised residue is dissolved In After addition of ml there hydrochloride which melt at 170 after from The starting material prepared by reacting with chloroacetone to form the amlnoketone mm catalytically reducing the in the presence of and heatin the resultant diamine 87 mm with Example By the method described Example 1 there from g mm and β propionyl g of 177 mm The Gtarting material is prepared by acylating mm of picre te with reacting the resultant 116 with to piperidine 127 and reducing the latter with lithium aluminium 15 3y the method described in 1 13 there is g 144 and g hydrochloride of 175 recrystallisation from methylene starting material prepared by reacting of picrate 184 with acetone to form the 94 mm catalytically reducing the latter in the presence of and heating the resultant diamine 89 mm with 16 3y the method described in Example 1 there is from 34 g 152 mm and g propionyl 29 g of 160 The starting material ie by reacting by catalytic hydrogenation lutidine by means of a catalyst at C 220 excess pressure and fractional distillation of the resultant isomer mm of picrate with chloroacetone to form the 3ninoketone 33 8 mm catalytically reducing the latter in the presence of and heating the resultant diamine 30 10 mm with Example 17 3y the method i Example 1 there is from g 153 mm and g propionyl g of The starting is prepared by reacting by catalytic hydrogenation of by means of a catalyst at VJ 220 excess pressure and fractional distillation of resultant isomer mixture mm of picrate 118 with chloroacetone to form the 95 mm catalytically reducin the latter in the presence of and heating the resultant diamine 88 mm with Example 18 In the described in Example two diastereomers can be detected by gas For 28 g of the isomer mixture are distributed in Crai apparatus between aqueous methanol ligroin in the proportion 1 1 ml each lower and upper 262 distributive steps and by evaporation of the fractions 45 there are obtained g of a crystallised isomer A which at after recrystallisation from petroleum the fractions 97 262 there are obtained 2 g of isomer B which at 62 after recrystallisation from petroleum The mixed melting point of A and 3 is below Example 19 By the method described in 1 there is from g 2 155 raa and 11 g propionyl g 2 of 163 mm The starting material prepared by reacting 2 by catalytic hydrogenation of by means of a catalyst at excess 60 mm with chloroacetone to form the aminoketone 93 catalytically reducing the latter in the presence of and heating the diamine 36 with 20 By the method described in Example 1 there is from 37 155 mm g propionyl g of 165 ma The starting eaterial is prepared by reacting h with chloroacetone to form th9 aminoketone mm catalytically reducing the latter in the presence of and heating the resultant diamine 32 with By the method described in 1 there is from g 153 mm ε g propionyl g of 1SS The starting material is prepared by reacting to form the ketone 96 catalytically reducing the latter in the presence and heating resultant diamine 83 with Example 22 3y the described in Example 1 there is from g 150 mm and g propionyl g of 170 mm The starting material is prepared by reacting copellidine of hydrochloride with to form the aminoketone 94 nun catalytically reducing the latter in the presence of and heating the resultant diamine 89 mm with Example 23 By the method described Example 1 there ie from g 154 mm and g propionyl g inopyridine of 170 starting material is prepared reacting by catalytic hydrogenation of by means of a cataly t 2 3 220 pressure and fractional distillation of the resultant isomer V7ith chloroacetone to form the 94 mn catalytically reducing the latter the presence of and the resultant 38 with 24 By the laethod described in 1 there is 65 and 13 g propionyl g of 170 starting material is prepared by reacting by catolytic hydrogenation of by means of a catalyst at 220 pressure and fractional distillation of the resultant isomer am with acetone to form the one 91 catalytically reducing the latter in the presence of and heating the resultant diamine 83 with fopogoing intondod not ae limitative ioationo of tho of and which all have aimilar ties and uses 25 By the method described in Example g of aminopyridine mm prepared from of aminopyridine mm and g of propionyl The starting material ie prepared by reacting with chloroacetone to form the amino ketone mm catalytically reducing the latter the presence of and heating the diamine formed mm with Example 26 By the method described in Example g of ne mm is prepared from g of aminopyridine mm and g of propionyl The starting material is prepared by reacting methylpiperidine with chloroacetone to form amino ketone mm catalytically reducing the latter in the presence of and heating the diamine formed mm with Example 27 By the method described in Example g of aminopyridine of mm Hg is prepared from g of and g of propionyl The starting material is prepared by reacting with chloroacetone to form the amino ketone mm catalytically hydrogenating the latter in presence of ammonia and heating the diamine formed mm with In the reaction product two diasteormers can be found by gas separation of the mixture is effected by means of counter current distribution to van in a syatem With constant purity control by gas chromatograph g of Isomer A are obtained from the light phase and g of Isomer B from the heavy 2Q By the method described in Example g of aminopyridine is prepared from g of the Isomer of amlnopy described in Example and g of propionyl According to gas chromatographic and spectroscopic the product still contains about of the Isomer A described in Example Example 29 3y the method described in Example g of aminopyridine of mm Hg is prepared from g mm and g of propionyl The starting material is prepared acyl ting with chloride and reacting the mixture of diasteormeric mm thus with From the mixture of diasteormeric thus an Isomer A of 116 and an Isomer B of can be isolated by fractional Reduction of both with lithium aluminium hydride produces two corresponding isomers A mm and an isomer The latter was present in a very small amount and ascertained by gas chromatography It was found to be homogeneous and different from Example By the method described in Example the reaction of of the Isomer B of described in Example 26 with g of propionyl chloride yields g of an oil which is found to be uniform and according to the and is the Isomer B of Example 31 By the method described in Example g of aminopyridine of mm Hg is prepared from 19 g of and g of propionyl The starting material prepared by acylating with chloride and reacting the mixture of diaateormerio 10 mm thus obtained with From the aiixture of fractionated by crystallization from methyl isobutyl the pure Isomer A of can be From the mother liquors of there can be by recrystallization from an ethyl petroleum ether the Isomer B which has a purity of 88 as determined and appears to be contaminated with Isomer Reduction with hydride affords the corresponding diastereomeric pyridines A and of 5 Kg and Example By the method described g of of is obtained from g of the isomer of Hg described in Example product is pure and spectrum shows it to be a isomers Example By the method described in Example g of pyridine of mm Hg is obtained from g of and g of propionyl material is prepared by hydrogenating under high pressure over in the presence of acylating the obtained with chloride to form mm reacting the latter with to compound and reducing this lithium aluminium 34 3y the method described in Example g of of is prepared by reacting g of mm with g of propionylchloride in a methylene chloride evaporation of the solvent in vacuum and crystallization of the residue from a mixture of methylene chloride and dry The starting material is prepared by acylating with reacting the tetrahydropyridine mm with to form tetrahydropyridine and reducing the latter with lithium Example 35 By the method described Example g of of mm Eg prepared from g of and of propionyl The starting material is prepared by acylating with propionyl reacting the with to form and reducing the latter with lithium aluminium Example 36 the method described in g of yridine of mm is prepared by reacting g of mm and g of propionyl The starting material is prepared by acylating mm Picrate with acid reacting the h lhexahydroazepine mm thus obtained with to form azepine and reducing the latter with lithium aluminium Example 37 By method described in Example g of of mm Hg is obtained from 25 of mm and of propionyl The starting material is prepared by acylating mm picrate with acid reacting the mm thus obtained with to form azepine mm and reducing the latter with lithium aluminium Example 38 By the method described in Example g of of mm Hg is obtained from g of mm and g of propionyl starting material is prepared by subjecting to a rearrangement to form the mm reducing this compound with lithium aluminium acylating of the azepine picrate thereby obtained with acid reacting the mm thus obtained with to form and reducing the latter with lithium aluminium The the method described in Example g of of Hg is obtained from 15 g of mm and 10 g of The starting material is prepared by of acid mm with cobalt and subjecting the lhexamethylene diamine mm to ring closure by catalytic splitting of ammonia with aluminium to form hexahydroazepine mm Hg 163 this latter compound is acylated with the mm is reacted with to form azepine and the latter is reduced with lithium aluminium Example the method described in Example g of of mm Hg is obtained from g of mm and g of propionyl The starting material is prepared by subjecting cyclohexanone mm to a Schmidt rearrangement to form the oxohexahydroazepine mm and reducing the latter with lithium aluminium hydrides the mm thus obtained is aoylated with a acid the mm thus obtained is reacted with to form and the latter is reduced with lithium aluminium 41 By the method described in Example g of of mm Hg mixture of is obtained from g of aminopyridine mm and S propionyl The starting material is prepared by hydrogenating acid dinitrile mm a mixture of with Baney nickel and subjecting the diamine mm to ring closure by catalytic splitting of ammonia with aluminium oxide to form 10 mm this latter compound is aoylated with propionic acid the hexahydroazepine mm is reacted with to form and the latter is reduced with lithium aluminium Example By the method described Example g of aminopyridine of mm Hg is obtained from 15 g of mm and g of propionyl The starting material is prepared by 2 with reacting the mm thus obtained to form piperidine mm and reducing the latter with lithium aluminium 28 Example The analgesic effect of some compounds according to the invention was compared with that of a corresponding known compound which differed from the compounds according to the invention bein unsubstituted in the heterocyclic For comparison the heat radiation test on the rat tail was In the the tail of male rats of to g body weight was irradiated with a focussed heat drug Animals to which no been reacted after an age time of irradiation of seconds by withdrawing the Under the influence of an analgesic dru the reaction time became Compounds which produced a reaction time of 20 seconds were considered analgesically Five animals were used for each dose of analgesic drug and the test period was 90 to 180 The established in these tests indicates 50 the dose at which the reaction time for an average of of the tested animals is prolonged to at least 20 The results of the tests are reported in Table I TABLE 1 Example Configuration R R 10 H 33 H 35 36 38 mixture 31 This Table shows that the dose required for longing the reaction of of the animals to more than 20 seconds much greater for the known compound than for the compounds according to the 32 insufficientOCRQuality
Claims (1)
- Pyridine compounds of the formula in which X is a saturated or unsaturated bivalent alkylene radical of 5 to 9 carbon atoms which is branched once or several times and forms with the nitrogen atom a to heterocyclic ring bearing at least one alkyl with the proviso that the total number of carbon atoms on the heterocyclic ring and the alkyl is from 5 to and is alkyl or alkenyl of 1 to 4 carbon and tically acceptable salts h 33 Analgesic compositions containing an effective amount of a compound according to any of Claims 1 to 11 in dosage For the Applicants AND PARTNERS insufficientOCRQuality
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE1967F0053582 DE1670930B2 (en) | 1967-09-25 | 1967-09-25 | N-PROPIONYL ANGLE CLAMP ON -1 (ALKYLAMINO) -ISOPROPYL ANGLE CLAMP FOR -2-AMINOPYRIDINE |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL30747A0 IL30747A0 (en) | 1968-11-27 |
| IL30747A true IL30747A (en) | 1972-08-30 |
Family
ID=7106440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL30747A IL30747A (en) | 1967-09-25 | 1968-09-20 | Acylated n-(alkylaminoalkyl)-aminopyridines |
Country Status (7)
| Country | Link |
|---|---|
| AT (1) | AT280285B (en) |
| DK (1) | DK118659B (en) |
| ES (1) | ES358484A1 (en) |
| FI (1) | FI49405C (en) |
| IL (1) | IL30747A (en) |
| NO (1) | NO124431B (en) |
| YU (1) | YU32934B (en) |
-
1968
- 1968-09-20 IL IL30747A patent/IL30747A/en unknown
- 1968-09-23 YU YU221568A patent/YU32934B/en unknown
- 1968-09-23 AT AT923968A patent/AT280285B/en active
- 1968-09-24 NO NO377068A patent/NO124431B/no unknown
- 1968-09-24 DK DK459868A patent/DK118659B/en unknown
- 1968-09-25 ES ES358484A patent/ES358484A1/en not_active Expired
- 1968-09-25 FI FI270868A patent/FI49405C/en active
Also Published As
| Publication number | Publication date |
|---|---|
| YU221568A (en) | 1975-06-30 |
| AT280285B (en) | 1970-04-10 |
| YU32934B (en) | 1975-12-31 |
| IL30747A0 (en) | 1968-11-27 |
| NO124431B (en) | 1972-04-17 |
| ES358484A1 (en) | 1970-04-16 |
| FI49405B (en) | 1975-02-28 |
| DK118659B (en) | 1970-09-21 |
| FI49405C (en) | 1975-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3714149A (en) | Pyridobenzodiazepinones | |
| US4435391A (en) | Dibenzoxazepine derivative, and pharmaceutical composition comprising the same | |
| US3567765A (en) | N-aromatic substituted acid amides and esters | |
| US2957872A (en) | Phthalimidines and process for manufacturing same | |
| US3123618A (en) | Io-dihydroanthkacene-z | |
| DE68915097T2 (en) | Apovincamic acid derivatives. | |
| FREED et al. | Syntheses of 1, 4-Diazabicyclo [4.4. 0] decanes, 1, 4-Diazabicyclo [4.3. 0] nonanes and 1, 8-Diazabicyclo [4.3. 0] nonanes | |
| DE3724520C2 (en) | New 3-aryl-3-cycloalkyl-piperidine-2,6-dione derivatives | |
| US2959594A (en) | Iso-benzmorphan derivatives | |
| Nagata et al. | Structure-activity relationships of tricyclic quinoxalinediones as potent antagonists for the glycine binding site of the NMDA receptor 1 | |
| EP0409119B1 (en) | N,N'-Bis(alkoxy-alkyl)-pyridine-2,4-dicarboxylic acid amides, process for their preparation as well as their use | |
| IL30747A (en) | Acylated n-(alkylaminoalkyl)-aminopyridines | |
| Thyrum et al. | p-Amino-N-[2-(substituted amino) ethyl] benzamides. Potential antifibrillatory drugs | |
| US2966493A (en) | Certificate of correction | |
| EP0300371A1 (en) | Hydrocinnamic acid derivatives | |
| DE2323956A1 (en) | SUBSTITUTED NAPHTHYLANTHRANILIC ACID | |
| US3987175A (en) | Derivatives of phenoxy isobutyric acid having hypolipemizing and hypocholesterolemizing action | |
| EP0001585B1 (en) | Piperazino-pyrrolobenzodiazepines, methods for their preparation and pharmaceutical compositions containing them | |
| US2784226A (en) | Nu-(cyclopropylmethyl)-cyclohexylamine | |
| US4178450A (en) | 2,5-Dimethyl-benzo(b) thiene (3,2-f) morphan and precursor thereof | |
| Ayral-Kaloustian et al. | Pyrolysis of the tosylhydrazone sodium salts of two bicyclic lactones | |
| Diamond et al. | Synthesis and properties of the analgesic DL-α-1, 3-dimethyl-4-phenyl-4-propionoxyazacycloheptane (Proheptazine) | |
| US2727898A (en) | Quaternary ammonium derivatives of benzodionoles | |
| EP0056617A2 (en) | Cycloheptene derivatives, process and intermediates for their preparation, and pharmceuticals containing them | |
| Rice et al. | Synthesis and analgesic activities of 2, 5-dimethyl-2'-hydroxy-9. alpha.-and-. beta.-propyl-6, 7-benzomorphans |